PREVENAR 20

Injektionssuspension in einer Fertigspritze, 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 4.4mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml
RezeptpflichtigAktive Zulassung

Wirkstoff (INN)

Pneumokokken-Polysaccharid-Konjugatimpfstoff, adsorbiert

Darreichungsform

DarreichungsformInjektionssuspension in einer Fertigspritze
Stärke2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 4.4mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml
VerpackungUkupno 1 napunjeni injekcioni špric sa 0.5ml suspenzije za injekciju (sa 1 iglom) u kartonskoj kutiji
HerstellerPfizer Manufacturing Belgium NV, Belgien
Therapeutische GruppeAntiinfektiva zur systemischen Anwendung (J07AL02)
Zulassungsinhaber"EVROPA LEK PHARMA" DOO PODGORICA
Zulassungsdatum20. September 2024

Analoga in Montenegro

5

Andere Arzneimittel mit demselben Wirkstoff

PREVENAR 13Rezeptpflichtig
Injektionssuspension in einer Fertigspritze, (2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 4.4mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg)/0.5mlPfizer Manufacturing Belgium NV
PREVENAR 13Rezeptpflichtig
Injektionssuspension in einer Fertigspritze, (2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 4.4mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg)/0.5mlPfizer Manufacturing Belgium NV
SYNFLORIXRezeptpflichtig
Injektionssuspension in einer Fertigspritze, (1mcg + 3mcg + 1mcg + 1mcg + 1mcg + 1mcg + 1mcg + 3mcg + 3mcg + 1mcg)/0.5mlGlaxoSmithKline Biologicals S.A.
VAXNEUVANCERezeptpflichtig
Injektionssuspension in einer Fertigspritze, (2mcg + 2mcg + 2mcg + 2mcg + 2mcg + 4mcg + 2mcg + 2mcg + 2mcg + 2mcg + 2mcg + 2mcg + 2mcg + 2mcg + 2mcg)/0.5mlMerck Sharp & Dohme B.V.
VAXNEUVANCERezeptpflichtig
Injektionssuspension in einer Fertigspritze, (2mcg + 2mcg + 2mcg + 2mcg + 2mcg + 4mcg + 2mcg + 2mcg + 2mcg + 2mcg + 2mcg + 2mcg + 2mcg + 2mcg + 2mcg)/0.5mlMerck Sharp & Dohme B.V.
Quelle: CInMED-Register